<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>148(10)</volume><submitter>Gambichler T</submitter><funding>Ruhr-Universität Bochum</funding><pubmed_abstract>&lt;h4>Purpose&lt;/h4>To evaluate the protein expression characteristics of genes employed in a recently introduced prognostic gene expression assay for patients with cutaneous melanoma (CM).&lt;h4>Methods&lt;/h4>We studied 37 patients with CM and 10 with benign (melanocytic) nevi (BN). Immunohistochemistry of primary tumor tissue was performed for eight proteins: COL6A6, DCD, GBP4, KLHL41, KRT9, PIP, SCGB1D2, SCGB2A2.&lt;h4>Results&lt;/h4>The protein expression of most markers investigated was relatively low (e.g., DCD, KRT9, SCGB1D2) and predominantly cytoplasmatic in melanocytes and keratinocytes. COL6A6, GBP4, and KLHL41 expression was significantly enhanced in CM when compared to BN. DCD protein expression was significantly correlated with COL6A6, GBP4, and KLHL41. GBP4 was positively correlated with K</pubmed_abstract><journal>Journal of cancer research and clinical oncology</journal><pagination>2673-2680</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9470607</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Protein expression of prognostic genes in primary melanoma and benign nevi.</pubmed_title><pmcid>PMC9470607</pmcid><pubmed_authors>Nick M</pubmed_authors><pubmed_authors>Kafferlein HU</pubmed_authors><pubmed_authors>Lang K</pubmed_authors><pubmed_authors>Bruckmuller S</pubmed_authors><pubmed_authors>Skrygan M</pubmed_authors><pubmed_authors>Gambichler T</pubmed_authors><pubmed_authors>Susok L</pubmed_authors><pubmed_authors>Schroder S</pubmed_authors><pubmed_authors>Stockfleth E</pubmed_authors><pubmed_authors>Meyer T</pubmed_authors><pubmed_authors>Elfering J</pubmed_authors><pubmed_authors>Wagener D</pubmed_authors><pubmed_authors>Bruning T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Protein expression of prognostic genes in primary melanoma and benign nevi.</name><description>&lt;h4>Purpose&lt;/h4>To evaluate the protein expression characteristics of genes employed in a recently introduced prognostic gene expression assay for patients with cutaneous melanoma (CM).&lt;h4>Methods&lt;/h4>We studied 37 patients with CM and 10 with benign (melanocytic) nevi (BN). Immunohistochemistry of primary tumor tissue was performed for eight proteins: COL6A6, DCD, GBP4, KLHL41, KRT9, PIP, SCGB1D2, SCGB2A2.&lt;h4>Results&lt;/h4>The protein expression of most markers investigated was relatively low (e.g., DCD, KRT9, SCGB1D2) and predominantly cytoplasmatic in melanocytes and keratinocytes. COL6A6, GBP4, and KLHL41 expression was significantly enhanced in CM when compared to BN. DCD protein expression was significantly correlated with COL6A6, GBP4, and KLHL41. GBP4 was positively correlated with K</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-26T22:27:52.432Z</modification><creation>2024-11-09T02:15:05.99Z</creation></dates><accession>S-EPMC9470607</accession><cross_references><pubmed>34757537</pubmed><doi>10.1007/s00432-021-03779-0</doi></cross_references></HashMap>